Related Experiment Videos
Vascular hemostasis in flowing blood in children
1Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Insights
Hemostasis differs across age groups, with newborns having unique procoagulant and anticoagulant features. These developmental hemostasis differences are crucial for understanding thrombosis risk in children and adults.
Area of Science:
- Pediatric Hematology
- Vascular Biology
- Hemostasis and Thrombosis
Background:
- Hemostasis, the process of stopping bleeding, exhibits significant age-related variations.
- Understanding these differences is critical for assessing thrombotic risk in pediatric and adult populations.
Purpose of the Study:
- To review age-specific differences in hemostasis, focusing on the vascular endothelium and blood flow dynamics.
- To identify unique procoagulant and anticoagulant features in newborn hemostasis.
- To explore the developmental nature of hemostasis and its implications for thrombotic risk.
Main Methods:
- Review of existing literature on hemostasis in newborns, children, and adults.
- Analysis of factors influencing hemostasis, including vascular endothelium function and blood flow.
- Comparison of procoagulant and anticoagulant mechanisms across different age groups.
Main Results:
- Newborns exhibit distinct procoagulant features: large von Willebrand factor multimers, enhanced platelet transport, and increased tissue factor generation by endothelium.
- Newborns also show unique anticoagulant features: higher glycosaminoglycan activity, elevated alpha2-macroglobulin, and increased free protein S.
- Hemostasis is developmentally regulated, generally effective across all ages but with specific adaptations.
Conclusions:
- Hemostasis is a dynamic, age-dependent process with distinct neonatal characteristics.
- Developmental vascular anomalies, alongside congenital hypercoagulable states and catheter use, represent potential thrombotic risks in children and adults.
Abstract:
This review considers differences in hemostasis among newborns, children, and adults from the standpoint of the vascular endothelium and, where appropriate, in the presence of flowing blood. Special procoagulant features of newborn hemostasis include unusually large von Willebrand factor multimers, augmented platelet transport under flow conditions, and greater ability of newborn endothelium to generate tissue factor. Special anticoagulant features in the newborn include increased vessel wall glycosaminoglycan activity, elevated alpha2-macroglobulin, and increased percentage of free protein S. The net effect of the differences is that hemostasis is generally achieved in all age groups but is developmental in nature. In addition to congenital hypercoagulable states and catheter placement, developmental vascular anomalies appear to constitute a thrombotic risk, at least in some children (and possibly adults).